Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Jiang, Lu ^a   Zeng, Xin ^a   Wang, Zhi ^a   Ji, Ning ^b   Zhou, Yu ^a   Liu, Xianting ^b   Chen, Qianming ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B1; CYTOCHROME C; ONCOPROTEIN; ORAL CANCER OVEREXPRESSED PROTEIN 1; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG; ORAOV1 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE REGULATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE FUNCTION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTO ONCOGENE; UTERINE CERVIX CANCER; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; UTERINE CERVIX TUMOR;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HELA CELLS; HUMANS; NEOPLASM PROTEINS; S PHASE; TUMOR STEM CELL ASSAY; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77349126542     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-20     Document Type: Article

References (34)

1. Huang X, Gollin SM, Raja S, Godfrey TE. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci 2002, 99:11369-11374. 10.1073/pnas.172285799, 123263, 12172009.
2. Komatsu Y, Hibi K, Kodera Y, Akiyama S, Ito K, Nakao A. TAOS1, a novel marker for advanced esophageal squamous cell carcinoma. Anticancer Res 2006, 26:2029-2032.
3. Xia J, Chen Q, Li B, Zeng X. Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features. Oral Oncol 2007, 43:508-514. 10.1016/j.oraloncology.2006.05.008, 17005439.
4. Jiang L, Zeng X, Yang H, Wang Z, Shen J, Bai J, Zhang Y, Gao F, Zhou M, Chen Q. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma. Int J Cancer 2008, 123:1779-1786. 10.1002/ijc.23734, 18688849.
5. Muller D, Millon R, Lidereau R, Engelmann A, Bronner G, Flesch H, Eber M, Methlin G, Abecassis J. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer B Oral Oncol 1994, 30:113-120.
6. Field JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol 1992, 28:67-76.
7. Baras A, Yu Y, Filtz M, Kim B, Moskaluk CA. Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification. Oncogene 2009, 28(32):2919-2. 10.1038/onc.2009.150, 19525979.
8. Choi YW, Bae SM, Kim YW, Lee HN, Kim YW, Park TC, Ro DY, Shin JC, Shin SJ, Seo JS, Ahn WS. Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer 2007, 17:687-696. 10.1111/j.1525-1438.2007.00834.x, 17504382.
9. Macville M, Schröck E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, Popescu N, Ried T. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 1999, 59:141-150.
10. Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci 2002, 99:1443-1448. 10.1073/pnas.032652399, 122210, 11818553.
11. Bantounas I, Phylactou LA, Uney JB. RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J Mol Endocrinol 2004, 33:545-557. 10.1677/jme.1.01582, 15591019.
12. Elmore S. A Review of Programmed Cell Death. Toxicol Pathol 2007, 35:495-516. 10.1080/01926230701320337, 2117903, 17562483.
13. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes & Dev 2003, 17:2481.
14. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Can Med Assoc J 2001, 164:1017-1025.
15. Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008, 17:1611-1622. 10.1158/1055-9965.EPI-07-2922, 2587113, 18628412.
16. Verleye L, Thomakos N, Edmondson RJ. Recurrent cervical cancer presenting as malignant pericarditis: case report and review of the literature. Eur J Gynaecol Oncol 2009, 30:193-195.
17. Jesudasan RA, Rahman RA, Chandrashekharappa S, Evans GA, Srivatsan ES. Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am J Hum Genet 1995, 56:705-715. 1801173, 7887426.
18. Bahnassy AA, Zekri AR, Alam El-Din HM, Aboubakr AA, Kamel K, El-Sabah MT, Mokhtar NM. The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. J Egypt Natl Canc Inst 2006, 18:292-302.
19. Zhang H, Gavin M, Dahiya A, Postigo A, Ma D, Luo R, Harbour J, Dean D. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000, 101:79-89. 10.1016/S0092-8674(00)80625-X, 10778858.
20. Xie S, Xie B, Lee MY, Dai W. Regulation of cell cycle checkpoints by polo-like kinases. Oncogene 2005, 24:277-286. 10.1038/sj.onc.1208218, 15640843.
21. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000, 60:3689-3695.
22. Yeo EJ, Ryu JH, Chun YS, Cho YS, Jang IJ, Cho H, Kim J, Kim MS, Park JW. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases. Cancer Res 2006, 66:6345-6352. 10.1158/0008-5472.CAN-05-4460, 16778212.
23. Innocente SA, Abrahamson JL, Cogswell JP, Lee JM. p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci 1999, 96:2147-2152. 10.1073/pnas.96.5.2147, 26751, 10051609.
24. Burz C, Berindan-Neagoe I, Balacescu O, Irimie A. Apoptosis in cancer: Key molecular signaling pathways and therapy targets. Acta Oncol 2009, 9:1-11.
25. Roy S, Nicholson DW. Cross-talk in cell death signaling. J Exp Med 2000, 192:F21-25. 10.1084/jem.192.8.F21, 11034612.
26. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003, 116:4077-4085. 10.1242/jcs.00739, 12972501.
27. Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 2009, 122:437-441. 10.1242/jcs.031682, 19193868.
28. Singh M, Singh N. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol Cell Biochem 2009, 325:107-119. 10.1007/s11010-009-0025-5, 19191010.
29. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997, 79:380-389. 10.1002/(SICI)1097-0142(19970115)79:2<380::AID-CNCR22>3.0.CO;2-W, 9010112.
30. Bahnassy AA, Zekri AR, Alam El-Din HM, Aboubakr AA, Kamel K, El-Sabah MT, Mokhtar NM. The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. J Egypt Natl Canc Inst 2006, 18:292-302.
31. Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, Kim DS, Lee JH. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 2001, 81:341-347. 10.1006/gyno.2001.6196, 11371120.
32. Jiang L, Yang HS, Wang Z, Zhou Y, Zhou M, Zeng X, Chen QM. ORAOV1-A correlates with poor differentiation in oral cancer. J Dent Res 2009, 88:433-438. 10.1177/0022034509336994, 19493886.
33. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA. SU a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 6656, 20:9018-9027.
34. Liu J, Prolla G, Rostagno A, Chiarle R, Feiner H, Inghirami G. Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DBRCA1 (17aa). Oncogene 2000, 19:2767-2773. 10.1038/sj.onc.1203599, 10851077.